Kevin S. Sr. Boyle - Nov 16, 2021 Form 4 Insider Report for ZIOPHARM ONCOLOGY INC (TCRT)

Role
Chief Executive Officer, Director
Signature
/s/ Cyndi Baily, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Nov 16, 2021
Transactions value $
$14,000
Form type
4
Date filed
11/17/2021, 03:53 PM
Previous filing
Aug 31, 2021
Next filing
Apr 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Purchase $1.24K +884 +0.1% $1.40 876K Nov 16, 2021 Direct
transaction TCRT Common Stock Purchase $12.8K +9.12K +1.04% $1.40 885K Nov 17, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.